Seprafilm cuts uterine adhesions
This article was originally published in Clinica
Genzyme's Seprafilm significantly reduced gynaecological adhesions in a trial presented at the European Society for Gynaecological Endoscopy in Brussels last week (December 8th). Dr Michael Diamond, professor of obstetrics and gynaecology at Wayne State University in Detroit, said that fibroid patients treated with the film have 37% fewer lesions than untreated women. The adhesions in the treated group were also significantly less severe and smaller, he added.
You may also be interested in...
China’s Bio-Thera Solutions has received approval from the country’s NMPA to launch a Phase I clinical study comparing the pharmacokinetics and safety of its proposed ustekinumab biosimilar to Johnson & Johnson’s blockbuster psoriasis drug Stelara, the latest in a string of the biotech company’s products to advance into clinical development.
A regulatory framework that encourages physicians to conduct experimental cell and gene therapies have propelled China to become a major developer of such promising cancer-treating tools, but insiders say three are a plethora issues at stake.